DXC Technology Stock Gets IBD Rating Lift

Blockhead
02-06

DXC Technology (DXC) stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 74.

X NOW PLAYING This Is Why The Fed Is Aiming For A Neutral Rate In 2025

IBD's proprietary RS Rating tracks market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.

Decades of market research reveals that the market's biggest winners typically have an 80 or better RS Rating in the early stages of their moves. See if DXC Technology stock can continue to show renewed price strength and hit that benchmark.


When To Sell Stocks To Lock In Profits And Minimize Losses


Is DXC Technology Stock A Buy?

DXC Technology stock is building a cup without handle with a 24.83 entry. See if the tech stock can clear the breakout price in volume at least 40% higher than normal.

Earnings growth declined in the most recent report from 33% to 7%. But revenue moved higher, from -6% to -5%.

DXC Technology stock earns the No. 24 rank among its peers in the Computer-Technical Services industry group. GitLab Cl A (GTLB), LiveRamp Holdings (RAMP) and Dave (DAVE) are among the top 5 highly rated stocks within the group.

YOU MAY ALSO LIKE:

MarketSurge's Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10